Year archive

Biotest AG — 2012 filings

All 51 regulatory filings released by Biotest AG (BIO3) in 2012, sourced directly from the official regulator.

51 Filings

2012 Period

2012 filings (51)

Filing	Released	Lang
Biotest AG: FDA Approves Biotest's BIVIGAM(TM), an Intravenous Immune Globulin (Human), 10% liquid Regulatory Filings	2012-12-20	English
Biotest AG: FDA Approves Bivigam TM Regulatory Filings	2012-12-20	English
Biotest AG: Biotest with new management team for research and regulatory affairs Board/Management Information	2012-12-13	English
Biotest AG: Biotest AG signs strategically significant agreement to market human albumin in China Regulatory Filings	2012-12-11	English
Biotest AG: Biotest starts clinical development programme of human fibrinogen concentrate to treat serious, life-threatening bleeding Legal Proceedings Report	2012-12-06	English
DGAP-DD: Biotest AG english Director's Dealing	2012-11-27	English
DGAP-DD: Biotest AG english Director's Dealing	2012-11-21	English
Biotest AG: Biotest increases EBT by 26% Earnings Release 9M 2012	2012-11-13	English
Investor Presentation 2012 Investor Presentation	2012-11-13	German
Investor Presentation 2012 Investor Presentation	2012-11-13	English
Q3 Report 2012 Interim / Quarterly Report 9M 2012	2012-11-13	German
Biotest AG: Biotest AG expands existing product portfolio with the marketing authorisation of Intratect 100 g/l (10%) Regulatory Filings	2012-10-24	English
DGAP-DD: Biotest AG english Director's Dealing	2012-08-21	English
Biotest AG: Biotest Group with double digit EBIT growth Earnings Release H1 2012	2012-08-13	English
Investor Presentation 2012 Investor Presentation	2012-08-13	English
Investor Presentation 2012 Investor Presentation	2012-08-13	German
Q2 Report 2012 Interim / Quarterly Report H2 2012	2012-08-13	English
6-Monatsbericht 2012 Interim / Quarterly Report H2 2012	2012-08-13	German
Biotest AG: Clinical Data on Efficacy and Safety of Bivigam(TM) accepted by FDA. Sales and profit guidance confirmed despite delays in US registration. Regulatory Filings	2012-08-07	English
Biotest AG: Biotest AG starts combination therapy study with BT-062 in multiple myeloma Regulatory Filings	2012-07-16	English
Datum:14.06.2012 AGM Information	2012-06-14	German
Investor Presentation 2012 Investor Presentation	2012-06-12	German
Investor Presentation 2012 Investor Presentation	2012-06-12	English
DGAP-DD: Biotest AG english Director's Dealing	2012-06-05	English
DGAP-DD: Biotest AG english Director's Dealing	2012-05-11	English
Biotest AG: Annual general meeting approves dividend AGM Information	2012-05-10	English
Biotest AG: Biotest Group reports substantially higher EBIT Earnings Release Q1 2012	2012-05-10	English
Q1 Report 2012 Interim / Quarterly Report Q1 2012	2012-05-10	English
3-Monatsbericht 2012 Interim / Quarterly Report Q1 2012	2012-05-10	German
Präsentation zur Hauptversammlung 2012 AGM Information	2012-05-10	German
Biotest AG: Preliminary investigation by public prosecution - Company rejects suspicions Legal Proceedings Report	2012-05-08	English
Biotest consolidates its outstanding position in the hepatitis B hyperimmunoglobulin market with the marketing authorisation of Fovepta and with the initial sales of Hepatect(R) in Brazil Regulatory Filings	2012-04-23	English
Datum:20.04.2012 Audit Report / Information FY 2011	2012-04-20	German
Biotest AG: Biotest announces clinical trial data for its new investigational Intravenous Immunoglobulin (IVIG) product for the US market Regulatory Filings	2012-04-11	English
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 10.05.2012 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2012-03-28	German
Biotest AG: Biotest reached an all-time high Profit after Tax Earnings Release FY 2011	2012-03-22	English
Biotest AG: BT-062 demonstrates rapid and complete tumor eradication in preclinical studies Regulatory Filings	2012-03-22	English
Annual Report 2011 Annual Report FY 2011	2012-03-22	English
Geschäftsbericht 2011 Annual Report FY 2011	2012-03-22	German
Investor Presentation 2012 Investor Presentation	2012-03-22	German
Investor Presentation 2012 Investor Presentation	2012-03-22	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-03-15	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-03-15	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-03-15	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-02-22	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-02-22	English
Declaration of Voting Results & Voting Rights Announcements 2012 Declaration of Voting Results & Voting Rights Announcements	2012-02-22	English
Biotest AG: Slight increase in sales of 2.3% despite difficult market environment Earnings Release FY 2011	2012-02-20	English
Report Publication Announcement 2012 Report Publication Announcement	2012-02-09	English
Hinweis auf Quartalsfinanzbericht vom 01.01.2012 bis zum 31.03.2012 Report Publication Announcement	2012-02-09	German
Datum:09.02.2012 Report Publication Announcement	2012-02-09	German

Filings by year

2025 34 filings
2024 50 filings
2023 46 filings
2022 53 filings
2021 73 filings
2020 46 filings
2019 36 filings
2018 71 filings
2017 81 filings
2016 57 filings
2015 68 filings
2014 42 filings
2013 52 filings
2012 51 filings
2011 47 filings
2010 64 filings
2009 56 filings
2008 50 filings
2007 37 filings
2006 28 filings
2005 31 filings
2004 17 filings
2003 30 filings
2002 10 filings
2001 1 filing
2000 2 filings
1999 3 filings
1998 7 filings
1997 5 filings